The role of terlipressin in pediatric septic shock: A review of the literature and personal experience

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 2, 2007, Pages 213-221

  Papoff, Paola ^a   Mancuso, M ^a   Barbara C S ^a   Moretti, C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Children; Septic shock; Terlipressin; Vasopressin

Indexed keywords

ANTIPYRETIC AGENT; CATECHOLAMINE; CEFTRIAXONE; CYCLIC AMP; DOBUTAMINE; DOPAMINE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LEVOSIMENDAN; NORADRENALIN; OXYTOCIN RECEPTOR; PLACEBO; TERLIPRESSIN; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR; VASOPRESSIN V3 RECEPTOR;

ABSENCE OF SIDE EFFECTS; ADD ON THERAPY; ANTIDIURESIS; BRADYCARDIA; CALCIUM CELL LEVEL; CLINICAL STUDY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DIURESIS; DOWN REGULATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; FEVER; HEART ARRHYTHMIA; HEART INFARCTION; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPOTENSION; HYPOVOLEMIA; ISCHEMIA; ISCHEMIC COLITIS; LISTERIA MONOCYTOGENES; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; MENINGOCOCCEMIA; METABOLIC ACIDOSIS; MOLECULAR BIOLOGY; NONHUMAN; OSMOREGULATION; PRIORITY JOURNAL; REFRACTORY PERIOD; REVIEW; RHABDOMYOLYSIS; SEPTIC SHOCK; SKIN NECROSIS; URINE VOLUME; VASOCONSTRICTION; VASODILATATION; VASOMOTOR REFLEX; VASOPRESSIN RELEASE;

EID: 34547130036     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000201     Document Type: Review

References (39)

1. Landry D.W. and J.A. Oliver. 2001. The pathogenesis of vasodilatory shock. N. Engl. J. Med. 345:588.
2. Beale R.J., S.M. Hollenberg, J.L. Vincent and J.E. Parrillo. 2004. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit. Care Med. 32(S):455.
3. Rivers E., B. Nguyen, S. Havstad, J. Ressler, A. Muzzin, B. Knoblich, E. Peterson and M. Tomlanovich; Early Goal-Directed Therapy Collaborative Group. 2001. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 345:1368.
4. Landry D.W., H.R. Levin, E.M. Gallant, R.C. Ashton Jr, S. Seo, D. D'Alessandro, M.C. Oz and J.A. Oliver. 1997. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95:1122.
5. Landry D.W., H.R. Levin, E.M. Gallant, S. Seo, D. D'Alessandro, M.C. Oz and J.A. Oliver. 1997. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit. Care Med. 25:1279.
6. Mutlu G.M. and P. Factor. 2004. Role of vasopressin in the management of septic shock. Intensive Care Med. 30:1276.
7. Sklar A.H. and R.W. Schrier. 1983. Central nervous system mediators of vasopressin release. Physiol. Rev. 63:1243.
8. Holmes C.L., B.M. Patel and J.A. Russell. 2001. Physiology of vasopressin relevant to management of septic shock. Chest 120:989.
9. Bourque C.W. 1998. Osmoregulation of vasopressin neurons: a synergy of intrinsic and synaptic processes. Prog. Brain Res. 119:59.
10. Delmas A., M. Leone, S. Rousseau, J. Albanese and C. Martin. 2005. Clinical review: vasopressin and terlipressin in septic shock patients. Crit. Care 9:212.
11. Kovacs L. and G.L. Robertson. 1992. Syndrome of inappropriate antidiuresis. Endocrinol. Metab. Clin. North Am. 21:859.
12. Birnbaumer M. 2000. Vasopressin receptors. Trends Endocrinol. Metab. 11:406.
13. Oyama H., Y. Suzuki, S. Satoh, Y. Kajita, M. Takayasu, M. Shibuya and K. Sugita. 1993. Role of nitric oxide in the cerebral vasodilatory responses to vasopressin and oxytocin in dogs. J. Cereb. Blood Flow Metab. 13:285.
14. Vanhoutte P.M., Z.S. Katusic and J.T. Shepherd. 1984. Vasopressin induces endothelium-dependent relaxations of cerebral and coronary, but not of systemic arteries. J. Hypertens. 2(S):421.
15. Haslam R.J. and G.M. Rosson. 1972. Aggregation of human blood platelets by vasopressin. Am. J. Physiol. 223:958.
16. Deen P.M., M.A. Verdijk, N.V. Knoers, B. Wieringa, L.A. Monnens, C.H. van Os and B.A. van Oost. 1994. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264:92.
17. Berl T. and G.L. Robertson. 2000. Pathophysiology of water metabolism. In The Kidney. B.M. Brenner, ed. Brenner & Rectors. Saunders, Philadelphia, p. 866.
18. Tamaki T., K. Kiyomoto, H. He, A. Tomohiro, A. Nishiyama, Y. Aki, S. Kimura and Y. Abe. 1996. Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles. Kidney Int. 49:722.
19. Nielsen S. and M.A. Knepper. 1993. Vasopressin activates collecting duct urea transporters and water channels by distinct physical processes. Am. J. Physiol. 265:204.
20. McVicar A.J. 1988. Dose-response effects of pressor doses of arginine vasopressin on renal haemodynamics in the rat. J. Physiol. 404:535.
21. Mannucci P.M., M. Aberg, I.M. Nilsson and B. Robertson. 1975. Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br. J. Haematol. 30:81.
22. Thibonnier M., D.M. Conarty, J.A. Preston, C.L. Plesnicher, R.A. Dweik and S.C. Erzurum. 1999. Human vascular endothelial cells express oxytocin receptors. Endocrinology 140:1301.
23. Okamura T., K. Ayajiki, H. Fujioka and N. Toda. 1999. Mechanisms underlying arginine vasopressin-induced relaxation in monkey isolated coronary arteries. J. Hypertens. 17:673.
24. Asfar P., M. Pierrot, N. Veal, F. Moal, F. Oberti, V. Croquet, O. Douay, Y. Gallois, J.L. Saumet, P. Alquier and P. Cales. 2003. Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit. Care Med. 31:215.
25. Nilsson G., P. Lindblom, M. Ohlin, R. Berling and E. Venersson. 1990. Pharmacokinetics of terlipressin after a single i.v. dose to healthy volunteers. Drugs Exp. Clin. Res. 16:307.
26. Zeballos G., J. Lopez-Herce, C. Fernandez, K.B. Brandstrup and A. Rodriguez-Nuñez. 2006. Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock. Resuscitation 68:151.
27. Luckner G., M.W. Dunser, S. Jochberger, V.D. Mayr, V. Wenzel, H. Ulmer, S. Schmid, H. Knotzer, W. Pajk, W. Hasibeder, A.J. Mayr and B. Friesenecker. 2005. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit. Care Med. 33:2659.
28. Ceneviva G., J.A. Paschall, F. Maffei and J.A. Carcillo. 1998. Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 102:19.
29. Lodha R., S. Vivekanandhan, M. Sarthi and S.K. Kabra. 2006. Serial circulating vasopressin levels in children with septic shock. Pediatr. Crit. Care Med 7:220.
30. Leclerc F., E. Walter-Nicolet, S. Leteurtre, O. Noizet, A. Sadik, R. Cremer and C. Fourier. 2003. Admission plasma vasopressin levels in children with meningococcal septic shock. Intensive Care Med. 9:1339.
31. Rodriguez-Nuñez A., M. Fernandez-Sanmartin, F. Martinon-Torres, N. Gonzalez-Alonso and J.M. Martinon-Sanchez. 2004. Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med. 30:477.
32. Rodriguez-Nunez A., J. Lopez-Herce, J. Gil-Anton, A. Hernandez, C. Rey and RETSPED Working Group of the Spanish Society of Pediatric Intensive Care. 2006. Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Crit. Care 10:20.
33. Peters M.J., R.A. Booth and A.J. Petros. 2004. Terlipressin bolus induces systemic vasoconstriction in septic shock. Pediatr. Crit. Care Med. 5:112.
34. Matok I., L. Leibovitch, A. Vardi, M. Adam, M. Rubinshtein, Z. Barzilay and G. Paret. 2004. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr. Crit. Care Med. 5:116.
35. Matok I., A. Vard, O. Efrati, M. Rubinshtein, T. Vishne, L. Leibovitch, M. Adam, Z. Barzilay and G. Paret. 2005. Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock 23:305.
36. Vasudevan A., R. Lodha and S.K. Kabra. 2005. Vasopressin infusion in children with catecholamine-resistant septic shock. Acta Paediatr. 94:380.
37. Efrati O., D. Modan-Moses, A. Vardi, I. Matok, Z. Bazilay and G. Paret. 2004. Intravenous arginine vasopressin in critically ill children: is it beneficial? Shock 22:213.
38. Meyer S., S. Gottschling, A. Baghai, D. Wurm and L. Gortner. 2006. Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury. Crit. Care 10:71.
39. Dunser M.W., A.J. Mayr, A. Tur, W. Pajk, F. Barbara, H. Knotzer, H. Ulmer and W.R. Hasibeder. 2003. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Crit. Care Med. 31:1394.